
Syneos Health SYNH
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Land |
|
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
104 M |
Marktkapitalisierung |
$ 4.46 B |
EBITDA (LTM) |
$ 391 M |
P/E (LTM) |
- |
P/S (LTM) |
0.84 |
EPS (LTM) |
0.91 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 17.65 | 3.67 % | $ 186 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 118.75 | 1.04 % | $ 36.1 B | NYSE,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 20.84 | 0.68 % | $ 1.11 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 1.59 | - | $ 2.12 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 24.63 | 0.11 % | $ 684 M | Nasdaq Global Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 186.62 | 0.66 % | $ 9.25 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 430.03 | -0.07 % | $ 12.4 B | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 15.12 | 1.44 % | $ 457 M | Nasdaq Global Market | ||
|
Myriad Genetics
MYGN
|
$ 3.97 | -21.17 % | $ 368 M | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 8.7 | -1.81 % | $ 1.11 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.29 | -2.4 % | $ 409 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 215.11 | 4.03 % | $ 21.2 B | Nasdaq Global Select Market,SPB | ||
|
Guardant Health
GH
|
$ 90.73 | 1.35 % | $ 11.4 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.06 | 2.31 % | $ 20 B | NYSE | ||
|
Personalis
PSNL
|
$ 5.96 | 7.1 % | $ 353 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 123.29 | 1.62 % | $ 10.2 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 141.08 | 1.45 % | $ 22.4 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 5.1 | 2.0 % | $ 213 M | NYSE American | ||
|
Soleno Therapeutics
SLNO
|
$ 52.93 | 0.02 % | $ 2.69 B | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 2.01 | 0.1 % | $ 8.89 M | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Biomerica
BMRA
|
$ 2.15 | -1.49 % | $ 4.94 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 86.12 | 0.35 % | $ 5.81 B | Nasdaq Global Select Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 473.2 | 1.38 % | $ 178 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.6 | 0.45 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 258.91 | 0.69 % | $ 21.5 B | NYSE,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 60.0 | 5.82 % | $ 3.59 B | Nasdaq Global Select Market,SPB | ||
|
Celcuity
CELC
|
$ 141.31 | -0.27 % | $ 6.61 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.29 | 0.22 % | $ 2.01 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 191.25 | 0.21 % | $ 21.2 B | NYSE,SPB | ||
|
Waters Corporation
WAT
|
$ 352.11 | 2.73 % | $ 21 B | NYSE,SPB |